-transparent.png){kind=logo}
In vitro salicylates /aspirin, salicylic acid, salicylamide and gentisic acid/ inhibited formation of 12-lipoxygenase products in intact human washed platelets which were stimulated with thrombin or arachidonic acid. Salicylates did not affect 12-lipoxygenase activity in platelet lysates. Ex vivo aspirin or salicylamide at a dose of 1 g given orally to healthy volunteers potentiated formation of 12-lipoxygenase products in washed platelets. It is concluded that the effect of salicylates on 12-lipoxygenase pathway is independent from their influence on cyclooxygenase activity in platelets and aspirin cannot be considered as a selective inhibitor of platelet cyclooxygenase.
M Radomski, and
Z Michalska, and
E Marcinkiewicz, and
R J Gryglewski
October 1986,
Biochimica et biophysica acta,
M Radomski, and
Z Michalska, and
E Marcinkiewicz, and
R J Gryglewski
January 2002,
Advances in experimental medicine and biology,
M Radomski, and
Z Michalska, and
E Marcinkiewicz, and
R J Gryglewski
January 1984,
Prostaglandins, leukotrienes, and medicine,
M Radomski, and
Z Michalska, and
E Marcinkiewicz, and
R J Gryglewski
January 1989,
Advances in prostaglandin, thromboxane, and leukotriene research,
M Radomski, and
Z Michalska, and
E Marcinkiewicz, and
R J Gryglewski
March 1985,
Biochemical and biophysical research communications,
M Radomski, and
Z Michalska, and
E Marcinkiewicz, and
R J Gryglewski
September 2006,
Molecular pharmacology,
M Radomski, and
Z Michalska, and
E Marcinkiewicz, and
R J Gryglewski
January 1989,
Advances in prostaglandin, thromboxane, and leukotriene research,
M Radomski, and
Z Michalska, and
E Marcinkiewicz, and
R J Gryglewski
January 1990,
International archives of allergy and applied immunology,
M Radomski, and
Z Michalska, and
E Marcinkiewicz, and
R J Gryglewski
May 1988,
Prostaglandins, leukotrienes, and essential fatty acids,
M Radomski, and
Z Michalska, and
E Marcinkiewicz, and
R J Gryglewski
April 1977,
Thrombosis and haemostasis,
